Literature DB >> 2789414

Effects of triiodothyronine (T3) on the potentiation by antidepressants of L-5-hydroxytryptophan-induced head-twitches in mice.

P Martin1, J Massol, P Soubrie, A J Puech.   

Abstract

1. Daily injection of T3 during three consecutive days dose-dependently enhanced L-5-HTP (4 mg/kg)-induced head-twitches in mice. 2. Pretreatment with a sub-effective dose of T3 (0.06 mg/kg) markedly enhanced the ability of drugs acting mainly on noradrenergic systems (clenbuterol, desipramine, maprotiline and nomifensine) to increase the response to L-5-HTP. 3. In contrast the potentiating effects of T3 were moderate on drugs with mixed action on serotonergic and noradrenergic systems (amitriptyline, clomipramine and imipramine) and minimal on drugs acting mainly on serotonergic systems (citalopram, fluvoxamine and indalpine). 4. These data suggest that the increased responsiveness to L-5-HTP caused by T3 involves an indirect (norepinephrine-mediated) rather than a direct effect on serotonergic processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2789414     DOI: 10.1016/0278-5846(89)90061-4

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  5 in total

1.  Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models.

Authors:  Dilip Kumar Pandey; Thangraj Devadoss; Neha Modak; Radhakrishnan Mahesh
Journal:  Indian J Med Res       Date:  2016-10       Impact factor: 2.375

2.  Reversal of helpless behavior by serotonin uptake blockers in rats.

Authors:  P Martin; P Soubrié; A J Puech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): an approach using rodent behavioral antidepressant tests.

Authors:  Shvetank Bhatt; Radhakrishnan Mahesh; Thangaraj Devadoss; Ankur Kumar Jindal
Journal:  Indian J Pharmacol       Date:  2013 Jul-Aug       Impact factor: 1.200

4.  Antidepressant Potential of 5-HT3 Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n).

Authors:  R Mahesh; S Bhatt; T Devadoss; Ak Jindal; Bk Gautam; Dk Pandey
Journal:  J Young Pharm       Date:  2012-10

5.  Antidepressant-like activity of (4-phenylpiperazin-1-yl) (quinoxalin-2-yl) methanone (4a), a novel 5-HT(3) receptor antagonist: an investigation in behaviour-based rodent models of depression.

Authors:  Radhakrishnan Mahesh; Baldev Kumar; Ankur Jindal; Shvetank Bhatt; Thangaraj Devadoss; Dilip Kumar Pandey
Journal:  Indian J Pharmacol       Date:  2012 Sep-Oct       Impact factor: 1.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.